Asclepii
Asclepii is a biomedical engineering company dedicated to revolutionizing regenerative medicine with a focus on making advanced therapies globally accessible and affordable. Founded by Franco Kraiselburd, the company develops innovative solutions such as Artemis™, a scalable tissue regeneration matrix that aims to transform wound care and organ manufacturing. With a mission to reduce costs and improve patient outcomes, Asclepii leverages cutting-edge research and global partnerships to scale its impact.
Industries
Nr. of Employees
small (1-50)
Products
Platform tissue-regeneration matrix (scaffold)
A hyper-scalable, collagen-enriched porous 3D extracellular matrix designed for wound healing and as a scaffold for cell or blood-based therapies; formulated for ambient storage and for incorporation of therapeutic additives.
Simplified cellular therapy format (point-of-care)
A simplified cell-therapy product format engineered for use with scaffold platforms to enable on-site or decentralized administration workflows.
Sensor-integrated monitoring dressing
Sensor modules embedded into scaffold materials to generate real-time physiologic data from wounds, feeding analytics pipelines for monitoring and clinical decision support.
Platform tissue-regeneration matrix (scaffold)
A hyper-scalable, collagen-enriched porous 3D extracellular matrix designed for wound healing and as a scaffold for cell or blood-based therapies; formulated for ambient storage and for incorporation of therapeutic additives.
Simplified cellular therapy format (point-of-care)
A simplified cell-therapy product format engineered for use with scaffold platforms to enable on-site or decentralized administration workflows.
Sensor-integrated monitoring dressing
Sensor modules embedded into scaffold materials to generate real-time physiologic data from wounds, feeding analytics pipelines for monitoring and clinical decision support.
Services
Clinical development and trial support
Design and support of early clinical evaluations and patient-use studies, and clinical affairs advisory services for wound-care and regenerative products.
Regulatory strategy and submission planning
Regulatory consulting focused on U.S. regulatory pathway planning and preparation of data and testing strategies for product approval.
Manufacturing scale-up and supply-chain partnerships
Partnership development and process support for scaling production, regional manufacturing, and distribution agreements.
Collaborative R&D partnerships
Collaborative research programs with universities and research centers to advance biomaterials, cell therapy integration and translational development.
Clinical development and trial support
Design and support of early clinical evaluations and patient-use studies, and clinical affairs advisory services for wound-care and regenerative products.
Regulatory strategy and submission planning
Regulatory consulting focused on U.S. regulatory pathway planning and preparation of data and testing strategies for product approval.
Manufacturing scale-up and supply-chain partnerships
Partnership development and process support for scaling production, regional manufacturing, and distribution agreements.
Collaborative R&D partnerships
Collaborative research programs with universities and research centers to advance biomaterials, cell therapy integration and translational development.
Expertise Areas
- Tissue engineering and regenerative medicine
- Wound care therapeutics and chronic wound management
- Biomaterials formulation and scaffold design
- Biomanufacturing scale-up and process development
Key Technologies
- Extracellular matrix scaffolds
- Collagen-enriched porous 3D matrices
- Semi-synthetic and stabilized biomaterial formulations
- Localized drug-delivery from scaffold matrices